ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway.

Junlu Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.